A 56-Year-Old Woman With Systemic Lupus Erythematosus on Trimethoprim-Sulfamethoxazole Prophylaxis Presenting With Breakthrough Nocardiosis
Abstract
BACKGROUND Patients with primary or secondary immunosuppression can be treated with trimethoprim-sulfamethoxazole (TMP-SMX) as long-term prophylaxis to prevent opportunistic infections. Nocardia africana/nova is an aerobic, gram-positive opportunistic organism. This case report describes a patient with systemic lupus erythematosus (SLE) on low-dose TMP-SMX prophylaxis who developed nocardiosis due to N. africana/nova. CASE REPORT A 56-year-old Chinese woman with SLE on long-term low-dose TMP-SMX prophylaxis underwent partial right lung lobectomy in July 2023 after incidental pulmonary lesions were detected. Pathology revealed a cryptococcal granuloma, which was treated with fluconazole. In November 2024, chest computed tomography (CT) showed progressive pulmonary nodules and right upper lobe consolidation despite antibacterial and antifungal therapy, including voriconazole guided by next-generation sequencing. CT-guided lung biopsy confirmed pulmonary nocardiosis caused by N. africana/nova, susceptible in vitro to TMP-SMX. High-dose TMP-SMX plus linezolid led to radiologic improvement, after which TMP-SMX monotherapy was continued. In March 2025, she was readmitted with acute altered mental status, recurrent cavitary pulmonary disease, pleural effusion, and multiple ring-enhancing cerebral abscesses, consistent with disseminated nocardiosis. Further aggressive treatment was declined, and she was discharged for palliative care. CONCLUSIONS Nocardiosis is challenging to…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.